Canopy Rivers Increases Investment in Italian Hemp Platform with $17.4 Million Financing
Marijuana Stocks, Finance, & InvestingUncategorized March 18, 2019
Canopy Rivers completed its investment in Canapar Company, an organic hemp production and processing platform.
Read more
Choom™ (CSE: CHOO; OTCQB: CHOOF) Completes Cannabis E-Commerce Platform
Marijuana Stocks, Finance, & InvestingUncategorized March 18, 2019
Choom™ (CSE: CHOO; OTCQB: CHOOF) announced that they have completed their proprietary cannabis e-commerce platform.
Read more
Aphria Receives Expanded Cannabis Production License at Aphria One
Marijuana Stocks, Finance, & InvestingUncategorized March 18, 2019
Aphria Inc. (TSX: APHA and NYSE: APHA) announced that Health Canada has granted the Company its license amendment, permitting Aphria to commence production in an additional 800,000 square feet of facilities at its Aphria One location
Read more
Altria Becomes Largest Shareholder in Cronos Group with C$2.4 Billion Investment
Marijuana Stocks, Finance, & InvestingUncategorized March 18, 2019
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) today announced that the C$2.4 billion equity investment in the Company by Altria Group, Inc. (NYSE: MO)] has closed.
Read more
SLANG Worldwide Launches RESERVE in California Market, and Expands O.penVAPE Brand Offering
Marijuana Stocks, Finance, & InvestingUncategorized March 18, 2019
SLANG Worldwide Inc. (CNSX: SLNG), a leading cannabis consumer packaged goods company, is pleased to announce the launch of its RESERVE product line in the California market. RESERVE further extends the O.penVAPE brand and complements SLANG’s existing product line.
Read more
InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate – INM-755 – for its Epidermolysis Bullosa Program InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate – INM-755 – for its Epidermolysis Bullosa Program
Marijuana Stocks, Finance, & Investing March 17, 2019 0
InMed Pharmaceuticals Announces Transition to a Single Cannabinoid Investigational Drug Candidate – INM-755 – for its Epidermolysis Bullosa Program
InMed Pharmaceuticals Inc. (TSX:IN; OTCQX:IMLFF), provided an update on its drug development program for the treatment of Epidermolysis Bullosa (“EB”).
Tiny Marijuana Stock Soars After Surprising Acquisition
Marijuana Stocks, Finance, & InvestingUncategorized March 16, 2019
Why this marijuana stock moved up big after vape company acquisition.
Read more
These “Comeback” Marijuana Stocks Are Roaring To Life (Up 23% In A Single Day)
Marijuana Stocks, Finance, & InvestingUncategorized March 16, 2019
The “dogs” of the marijuana stock sector are roaring back to life. But looking ahead a few months, their future may be the brightest of all marijuana stocks. Best of all, they’ve got a lot more “catching up” to do so there’s plenty of room to run. Here’s the full story these marijuana…
Read more
HEXO Corp Gets HIP With Newstrike Purchase 
HEXO Corp Gets HIP With Newstrike Purchase
HEXO has acquired Newstrike Brands (TSX.V: HIP) in an all stock deal worth approximately $260M Canadian.
Billionaire Nelson Peltz Joins Aurora Cannabis Billionaire Nelson Peltz Joins Aurora Cannabis
Marijuana Stocks, Finance, & Investing March 16, 2019 0
Billionaire Nelson Peltz Joins Aurora Cannabis
Nelson Peltz, the billionaire CEO and founding partner of Trian Fund Management, is joining Aurora Cannabis (ACB) as a Strategic Advisor.
